Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)
1.0300
+0.0300 (3.00%)
NASDAQ · Last Trade: Apr 30th, 11:45 PM EDT
Detailed Quote
Previous Close
1.000
Open
0.9685
Bid
1.140
Ask
1.150
Day's Range
0.9576 - 1.050
52 Week Range
0.1247 - 5.590
Volume
10,107,189
Market Cap
1.10M
PE Ratio (TTM)
-0.2048
EPS (TTM)
-5.0
Dividend & Yield
N/A (N/A)
1 Month Average Volume
620,890
Chart
About Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. is a biotechnology company focused on advancing innovative solutions for cancer treatment through its development of novel therapeutics. The company specializes in research aimed at improving the effectiveness of existing cancer therapies, particularly by enhancing the response of cancer cells to radiation and chemotherapy. Shuttle Pharmaceuticals is dedicated to leveraging scientific advancements to create new medications that enhance patient outcomes and quality of life, demonstrating its commitment to addressing significant challenges in oncology. Through its proprietary technologies and drug development programs, the company strives to bring transformative therapies to market that can better support cancer patients and their healthcare providers. Read More
Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive...
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Rockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced...
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
In the laboratories of modern medicine, time is the ultimate constraint. Every discovery competes against the clock: the years it takes to identify a viable molecule, the millions consumed by failed trials, and the patients waiting while the process plays out. The cost of delay is measured not only in dollars but also in lives.
